Gene Predictis Overview
- Year Founded
-
2004
- Status
-
Acquired/Merged
- Employees
-
3
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
4
Gene Predictis General Information
Description
Developer of polygenic and multifactorial risk scores intended for interpreting complex genetic data. The company develops precision medicines and other diagnostic tools based on genetics that allow tailored treatments to improve drug treatment efficacy and significantly reduce harmful side effects resulting from adverse drug reactions for patients, thus providing physicians with genetic and molecular microbiology analyses for precise clinical results.
Contact Information
Website
www.genepredictis.com(Operating Subsidiary)
Corporate Office
- EPFL Innovation Park
- Building B
- 1015 Lausanne
- Switzerland
Corporate Office
- EPFL Innovation Park
- Building B
- 1015 Lausanne
- Switzerland
Gene Predictis Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Gene Predictis Patents
Gene Predictis Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3333267-A1 | Method and kit for predicting the risk of deep vein thrombosis and pulmonary embolism | Inactive | 09-Dec-2016 | ||
| WO-2018104545-A1 | Method and kit for predicting the risk of deep vein thrombosis and pulmonary embolism | Inactive | 09-Dec-2016 | ||
| WO-2018104549-A1 | Method for predicting the risk of deep vein thrombosis and pulmonary embolism associated with hormonal preparations and hormone levels | Inactive | 09-Dec-2016 | ||
| WO-2018104549-A4 | Method for predicting the risk of deep vein thrombosis and pulmonary embolism associated with hormonal preparations and hormone levels | Inactive | 09-Dec-2016 | C12Q1/6883 |
Gene Predictis Signals
Gene Predictis Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Gene Predictis FAQs
-
When was Gene Predictis founded?
Gene Predictis was founded in 2004.
-
Where is Gene Predictis headquartered?
Gene Predictis is headquartered in Lausanne, Switzerland.
-
What is the size of Gene Predictis?
Gene Predictis has 3 total employees.
-
What industry is Gene Predictis in?
Gene Predictis’s primary industry is Laboratory Services (Healthcare).
-
Is Gene Predictis a private or public company?
Gene Predictis is a Private company.
-
What is Gene Predictis’s current revenue?
The current revenue for Gene Predictis is .
-
How much funding has Gene Predictis raised over time?
Gene Predictis has raised $497K.
-
Who are Gene Predictis’s investors?
EPFL Innovation Park has invested in Gene Predictis.
-
When was Gene Predictis acquired?
Gene Predictis was acquired on 13-Feb-2023.
-
Who acquired Gene Predictis?
Gene Predictis was acquired by NIMGenetics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process